<?xml version="1.0" encoding="ISO-8859-1"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:html="http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"><channel><atom:link href="http://www.theheart.org/rssfeed.do" rel="self" type="application/rss+xml" /><title>theHeart.org</title><link>http://www.theheart.org/</link><description></description><image> <url>http://www.theheart.org/documents/sitestructure/resources/images/maintho_logo_rss.png</url> <title>theHeart.org</title> <link>http://www.theheart.org/</link></image>	<item>	<link>http://www.theheart.org/article/1019761.do</link>	<title>Interventional cardiologist Donald Baim dies </title>	<description>		   <![CDATA[ Interventional cardiologist, <b>Dr Donald Baim</b>, chief medical and scientific officer at Boston Scientific, has died. ]]>		</description>	<pubDate>	vie, 06 nov 2009 18:22:01 EST	</pubDate>	<guid>http://www.theheart.org/article/1019761.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1019675.do</link>	<title>Latest European and US STEMI guidelines compared and contrasted </title>	<description>		   <![CDATA[ The latest recommendations for the treatment of ST-elevation MI issued by American cardiology associations and the European Society of Cardiology are compared and contrasted in a new paper.  ]]>		</description>	<pubDate>	vie, 06 nov 2009 17:15:26 EST	</pubDate>	<guid>http://www.theheart.org/article/1019675.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1019651.do</link>	<title>Enrollment halts in randomized trial of CPR for out-of-hospital arrest</title>	<description>		   <![CDATA[ No survival differences after out-of-hospital cardiac arrest were seen at a preliminary DSMB review in the ROC PRIMED trial, which compared early vs delayed post-CPR assessment for defibrillation and tested the effectiveness of a device for optimizing intrathoracic pressure during CPR.    ]]>		</description>	<pubDate>	vie, 06 nov 2009 16:00:39 EST	</pubDate>	<guid>http://www.theheart.org/article/1019651.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1019439.do</link>	<title>Medicaid access to smoking cessation falls short</title>	<description>		   <![CDATA[ A national survey shows that although the majority of state Medicaid programs offer coverage for some form of tobacco-dependence treatment, most fall far short of a stated mandate to provide unrestricted access to approved therapies. ]]>		</description>	<pubDate>	jue, 05 nov 2009 17:30:46 EST	</pubDate>	<guid>http://www.theheart.org/article/1019439.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1019417.do</link>	<title>Serum phosphorous, kidney function predict CAC</title>	<description>		   <![CDATA[ The Spokane Heart Study finds a connection between kidney function, serum phosphorus, and the risk of coronary artery calcification. ]]>		</description>	<pubDate>	jue, 05 nov 2009 17:00:00 EST	</pubDate>	<guid>http://www.theheart.org/article/1019417.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1019315.do</link>	<title>Low-cholesterol/cancer studies should &quot;dispel lingering doubts&quot; of causal link </title>	<description>		   <![CDATA[ Two new papers should help put to rest concerns that low serum cholesterol levels may increase cancer risk.  ]]>		</description>	<pubDate>	jue, 05 nov 2009 14:15:24 EST	</pubDate>	<guid>http://www.theheart.org/article/1019315.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1019233.do</link>	<title>Not all metabolic syndrome is created equal: Framingham Offspring analysis</title>	<description>		   <![CDATA[ The syndrome (defined by ATP III criteria) can predict increased cardiovascular and mortality risk or not, depending on which three of five risk factors contributed to the diagnosis, a cohort study suggests; its investigators caution that their observations are only preliminary.   ]]>		</description>	<pubDate>	jue, 05 nov 2009 11:45:03 EST	</pubDate>	<guid>http://www.theheart.org/article/1019233.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1019179.do</link>	<title>Prehospital triage &quot;immediately successful&quot; in boosting rates of thrombolytic therapy for stroke</title>	<description>		   <![CDATA[ Toronto researchers report that a citywide prehospital protocol raised their rates of thrombolytic treatment to among the highest in North America, underlining, they say, the critical importance of organized stroke care.   ]]>		</description>	<pubDate>	jue, 05 nov 2009 11:00:44 EST	</pubDate>	<guid>http://www.theheart.org/article/1019179.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1019089.do</link>	<title>Better survival in hospitalized flu patients on statins</title>	<description>		   <![CDATA[ Statin users hospitalized for influenza experienced a 54% lower risk of death compared with patients not taking statins.  ]]>		</description>	<pubDate>	mié, 04 nov 2009 17:30:28 EST	</pubDate>	<guid>http://www.theheart.org/article/1019089.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1019025.do</link>	<title>Off-pump CABG shows no benefit over on-pump approach: ROOBY study</title>	<description>		   <![CDATA[ A 2203-patient randomized trial of off-pump vs on-pump CABG surgery found no differences in neuropsychological outcomes and worse overall outcomes for the off-pump group at one-year follow-up. ]]>		</description>	<pubDate>	mié, 04 nov 2009 17:00:00 EST	</pubDate>	<guid>http://www.theheart.org/article/1019025.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1018999.do</link>	<title>VELETI in print: Plaque sealing of SVGs a strategy &quot;ahead of its time&quot;?</title>	<description>		   <![CDATA[ The imaging study was the first to show that stenting a non-flow-limiting stenosis of an SVG may help slow or halt the accelerated atherosclerosis that takes place in these vessels. An accompanying editorial cautions that the study does little more than "infer a trend toward anatomic benefit."  ]]>		</description>	<pubDate>	mié, 04 nov 2009 15:30:23 EST	</pubDate>	<guid>http://www.theheart.org/article/1018999.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1018939.do</link>	<title>Adding fuel to the J-curve fire; debate is reignited </title>	<description>		   <![CDATA[ More discussion about the J-curve in hypertension is published this week; one expert believes the undue attention being paid to this subject might discourage doctors from treating high blood pressure aggressively. ]]>		</description>	<pubDate>	mié, 04 nov 2009 14:30:56 EST	</pubDate>	<guid>http://www.theheart.org/article/1018939.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1018889.do</link>	<title>No CV risk reduction with B vitamins posttransplant </title>	<description>		   <![CDATA[ In keeping with all the other evidence showing no effects of homocysteine-lowering with B vitamins, the FAVORIT study now confirms that this lack of benefit is also seen in renal-transplant recipients.   ]]>		</description>	<pubDate>	mié, 04 nov 2009 13:15:27 EST	</pubDate>	<guid>http://www.theheart.org/article/1018889.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1018751.do</link>	<title>Another in-hospital CV risk marker: 24-hour shifts with overnight on-call duty </title>	<description>		   <![CDATA[ Long work shifts with nighttime on-call duty, with the inevitable interruptions of sleep, are associated with ECG, blood-pressure, and biochemical changes associated with increased cardiovascular risk, suggests a randomized crossover study that hints at a sustained effect on the risk markers if the 24-hour shifts happen too frequently.   ]]>		</description>	<pubDate>	mié, 04 nov 2009 09:45:43 EST	</pubDate>	<guid>http://www.theheart.org/article/1018751.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1018713.do</link>	<title>CAC scoring plus SPECT provide long and short view of cardiac risk</title>	<description>		   <![CDATA[ <b><i>UPDATED </i></b>// An 1126-patient trial shows that SPECT and CAC scoring imaging tests are independent and complementary predictors of short- and long-term cardiac risk, respectively. ]]>		</description>	<pubDate>	mar, 03 nov 2009 17:00:51 EST	</pubDate>	<guid>http://www.theheart.org/article/1018713.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1018685.do</link>	<title>Interventional cardiologist sues hospital under Whistleblower&#39;s Act </title>	<description>		   <![CDATA[ Dr David Gossman has filed a lawsuit claiming that he was fired for complaining about ties between the hospital and some of its senior staff with the medical device company Medtronic.  ]]>		</description>	<pubDate>	mar, 03 nov 2009 15:15:34 EST	</pubDate>	<guid>http://www.theheart.org/article/1018685.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1018639.do</link>	<title>US updates advice on perioperative beta-blocker use in noncardiac surgery </title>	<description>		   <![CDATA[ A US update on the perioperative use of beta blockers for noncardiac surgery is, says the lead author,  "similar" to recent European guidance on this issue. ]]>		</description>	<pubDate>	mar, 03 nov 2009 14:30:32 EST	</pubDate>	<guid>http://www.theheart.org/article/1018639.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1018593.do</link>	<title>FDA expands exenatide use; warns of renal-failure risk</title>	<description>		   <![CDATA[ The FDA has issued a warning about exenatide the same day the agency approved its first-line use along with diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus. ]]>		</description>	<pubDate>	mar, 03 nov 2009 13:15:00 EST	</pubDate>	<guid>http://www.theheart.org/article/1018593.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1018537.do</link>	<title>CMS set to cut Medicare physician fees for cardiovascular imaging </title>	<description>		   <![CDATA[ The 2010 Medicare Physician Fee Schedule final rule released by the CMS makes major cuts to several cardiovascular imaging services. ]]>		</description>	<pubDate>	mar, 03 nov 2009 11:45:09 EST	</pubDate>	<guid>http://www.theheart.org/article/1018537.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1018387.do</link>	<title>CORONA analysis reopens door for statins in heart failure </title>	<description>		   <![CDATA[ Statins for heart failure? After they failed to show much effect in two large randomized trials? Yes&#151;maybe; at least in patients with ischemic heart failure who start the drugs early enough, suggests a post hoc analysis based on one of the trials. ]]>		</description>	<pubDate>	mar, 03 nov 2009 10:45:33 EST	</pubDate>	<guid>http://www.theheart.org/article/1018387.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1018109.do</link>	<title>Combined home/GP hypertension control program successful in Pakistan </title>	<description>		   <![CDATA[ A synergistic approach of educating general practitioners about hypertension control together with a program to send lay workers into people's homes to educate them about the management of high blood pressure has proven successful in low- to middle-income households in Pakistan.  ]]>		</description>	<pubDate>	lun, 02 nov 2009 17:00:00 EST	</pubDate>	<guid>http://www.theheart.org/article/1018109.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1017689.do</link>	<title>Advocates build support for Canadian Heart Health Strategy in a difficult environment</title>	<description>		   <![CDATA[ Supporters of the Canadian Heart Health Strategy and Action Plan continue to solicit support from physicians and the public for a comprehensive strategy for improving Canadian's heart health at both the provincial and federal level. ]]>		</description>	<pubDate>	lun, 02 nov 2009 11:15:59 EST	</pubDate>	<guid>http://www.theheart.org/article/1017689.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1017579.do</link>	<title>No TREAT: Darbepoetin alfa fails to reduce CV or renal events in anemic diabetics with CKD </title>	<description>		   <![CDATA[ No differences were seen between groups, except in strokes, which were twice as high in the active-treatment group. Anticipated improvements in fatigue scores were modest and not clinically meaningful, investigators say.  ]]>		</description>	<pubDate>	vie, 30 oct 2009 20:41:45 EDT	</pubDate>	<guid>http://www.theheart.org/article/1017579.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1017525.do</link>	<title>Blood type of pig may be factor in longevity of porcine replacement heart valves</title>	<description>		   <![CDATA[ Researchers in Ottawa find that the longevity of porcine replacement heart valves may depend partly on whether the blood type of the patient matches the blood type of the valve's "original owner." ]]>		</description>	<pubDate>	vie, 30 oct 2009 16:45:00 EDT	</pubDate>	<guid>http://www.theheart.org/article/1017525.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1017487.do</link>	<title>Imaging study shows plaque regression with niacin vs placebo </title>	<description>		   <![CDATA[ Just weeks before ARBITER-HALTS 6 results come out at AHA 2009, an MRI study suggests that niacin is better than placebo in statin-treated patients with low HDL, at least for reducing carotid wall area. Experts say they'd also like to see insights into niacin effects on lipid-rich plaque volumes&#151;the more commonly seen end point with MRI.  ]]>		</description>	<pubDate>	vie, 30 oct 2009 16:00:00 EDT	</pubDate>	<guid>http://www.theheart.org/article/1017487.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1017341.do</link>	<title>Lifestyle-based diabetes prevention seen to endure for at least a decade</title>	<description>		   <![CDATA[ The protective effects of diet modification, exercise, and other lifestyle changes against new-onset diabetes showcased in the three-year Diabetes Prevention Program continued out to 10 years in a follow-up analysis.    ]]>		</description>	<pubDate>	vie, 30 oct 2009 10:00:00 EDT	</pubDate>	<guid>http://www.theheart.org/article/1017341.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1017153.do</link>	<title>Combination drugs for weight loss</title>	<description>		   <![CDATA[ Two studies presented this week have shown positive effects on weight loss using a combination of agents. ]]>		</description>	<pubDate>	jue, 29 oct 2009 15:30:33 EDT	</pubDate>	<guid>http://www.theheart.org/article/1017153.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1017037.do</link>	<title>Benefits of targeted lead placement with CRT devices supported by long-term mortality data</title>	<description>		   <![CDATA[ An additional year of data from the INCREMENTAL study showed that echo-targeted LV lead positioning increased the likelihood of a response to device therapy by about 40% over standard lead placement. But does that difference translate into better long-term outcomes for the patient? ]]>		</description>	<pubDate>	jue, 29 oct 2009 15:00:55 EDT	</pubDate>	<guid>http://www.theheart.org/article/1017037.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1016897.do</link>	<title>CRP predicts mortality and MI, but not stroke</title>	<description>		   <![CDATA[ A new analysis from the Northern Manhattan Study finds that high-sensitivity C-reactive protein was modestly associated with mortality and MI but not ischemic stroke in this multiethnic population, suggesting the predictive value may depend on other factors.  ]]>		</description>	<pubDate>	jue, 29 oct 2009 12:00:54 EDT	</pubDate>	<guid>http://www.theheart.org/article/1016897.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1016975.do</link>	<title>First trial of viral-derived protein agent shows promise as anti-inflammatory ACS therapy</title>	<description>		   <![CDATA[ Inflammatory responses contribute to coronary plaque rupture, thrombosis, and vascular occlusion. Some viruses have proteins that interfere with these inflammatory responses. Researchers have identified a viral-derived protein that may eventually be an anti-inflammatory treatment for coronary syndromes. ]]>		</description>	<pubDate>	jue, 29 oct 2009 11:45:16 EDT	</pubDate>	<guid>http://www.theheart.org/article/1016975.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1016867.do</link>	<title>Sex differences in changing MI prevalence, mortality challenge conventional wisdom </title>	<description>		   <![CDATA[ Two well-known observational registries highlight such changes in women and men over a decade or more: Do women younger than 55 still have an advantage over men in the same age group? ]]>		</description>	<pubDate>	jue, 29 oct 2009 10:30:28 EDT	</pubDate>	<guid>http://www.theheart.org/article/1016867.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1016067.do</link>	<title>Underutilization of ICDs in CABG patients is worst in women and elderly, Halifax study shows</title>	<description>		   <![CDATA[ Only 101 of 1169 post-bypass-surgery patients eligible for an ICD got one over a 13-year period in Nova Scotia.  ]]>		</description>	<pubDate>	mié, 28 oct 2009 16:45:37 EDT	</pubDate>	<guid>http://www.theheart.org/article/1016067.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1016657.do</link>	<title>Schizophrenia plus diabetes linked with higher CAD yet lower revascularization rates</title>	<description>		   <![CDATA[ Individuals with schizophrenia and diabetes&#151;as opposed to diabetes only&#151;have a greater risk of CAD but a smaller likelihood of receiving CABG or PCI, a large cohort study suggests. ]]>		</description>	<pubDate>	mié, 28 oct 2009 16:30:56 EDT	</pubDate>	<guid>http://www.theheart.org/article/1016657.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1016585.do</link>	<title>Bariatric surgery fails to reduce risk of MI long term</title>	<description>		   <![CDATA[ After a median follow-up of 12 years, MI rates were essentially the same among those treated with surgery and those who received conventional care for weight loss. ]]>		</description>	<pubDate>	mié, 28 oct 2009 14:30:14 EDT	</pubDate>	<guid>http://www.theheart.org/article/1016585.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1016557.do</link>	<title>Non-CV mortality also important in dialysis patients</title>	<description>		   <![CDATA[ Physicians may tend to overlook risk factors for noncardiovascular mortality in patients starting dialysis, since the emphasis in the past has always been on cardiovascular risk, researchers say.  ]]>		</description>	<pubDate>	mié, 28 oct 2009 14:15:19 EDT	</pubDate>	<guid>http://www.theheart.org/article/1016557.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1016353.do</link>	<title>Lorcaserin passes weight-loss and valvular hurdles in BLOSSOM study</title>	<description>		   <![CDATA[ Among overweight patients, including those with preexisting echocardiographic valvulopathy, the average weight loss was approximately 5 kg with lorcaserin. Importantly, there were no concerns raised about new or worsening cardiac valve problems with the 5HT2C-receptor agonist. ]]>		</description>	<pubDate>	mar, 27 oct 2009 16:15:27 EDT	</pubDate>	<guid>http://www.theheart.org/article/1016353.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1016171.do</link>	<title>Contrary to common belief, women feel same heart-attack symptoms as men</title>	<description>		   <![CDATA[ Women and men have the same rates of chest pain and other classic symptoms during ACS, although women are more likely to experience some other symptoms such as jaw and neck pain. ]]>		</description>	<pubDate>	mar, 27 oct 2009 14:30:23 EDT	</pubDate>	<guid>http://www.theheart.org/article/1016171.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1015869.do</link>	<title>Stent pioneer Julio Palmaz urges DES makers to &quot;learn from mistakes of the past&quot; </title>	<description>		   <![CDATA[ Speaking at the 30th anniversary of the GISE Congress, Palmaz said he'd never believed drug elution was the way forward for stents and outlined his theories for why coatings of any kind disrupt the healing properties of metallic coronary stents. ]]>		</description>	<pubDate>	mar, 27 oct 2009 13:00:38 EDT	</pubDate>	<guid>http://www.theheart.org/article/1015869.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1015993.do</link>	<title>Blood products should be used conservatively in heart-surgery patients, trial shows</title>	<description>		   <![CDATA[ Administration of blood products to stable patients post-cardiac surgery increases their risk of death, renal failure, and sepsis, according to new research. ]]>		</description>	<pubDate>	mar, 27 oct 2009 12:15:25 EDT	</pubDate>	<guid>http://www.theheart.org/article/1015993.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1015749.do</link>	<title>ACCORD update: &quot;One size fits all&quot; may not be best glucose-lowering strategy </title>	<description>		   <![CDATA[ While post hoc analyses of ACCORD data suggest there are subgroups of diabetic patients who may not benefit from an aggressive glucose-lowering approach, similar analyses with ADVANCE data did not identify subgroup differences.    ]]>		</description>	<pubDate>	mar, 27 oct 2009 10:00:02 EDT	</pubDate>	<guid>http://www.theheart.org/article/1015749.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1015787.do</link>	<title>Experts weigh in on calorie lists on menus, despite &quot;mixed&quot; science</title>	<description>		   <![CDATA[ Results showing that people eat less when they know how many calories are in that Big Mac are mixed, but experts say that menu labeling provides only upside, with no public-health cost, and that over time results will show the information to have a positive effect on obesity rates in the US. ]]>		</description>	<pubDate>	lun, 26 oct 2009 16:45:21 EDT	</pubDate>	<guid>http://www.theheart.org/article/1015787.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1015565.do</link>	<title>Distribution of body fat important in VTE </title>	<description>		   <![CDATA[ The distribution of body fat, as well as the amount, is important when it comes to the risk of venous thromboembolism, Danish researchers have discovered.  ]]>		</description>	<pubDate>	lun, 26 oct 2009 16:00:00 EDT	</pubDate>	<guid>http://www.theheart.org/article/1015565.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1015489.do</link>	<title>NRMI data raise more questions about PCI in nonsurgery centers</title>	<description>		   <![CDATA[ A new analysis of national registry data suggests that the superior outcomes of NSTEMI patients in hospitals with open-heart-surgery capabilities vs those without it are due to their size, procedure volume, and adherence to medication guidelines.  ]]>		</description>	<pubDate>	lun, 26 oct 2009 13:00:23 EDT	</pubDate>	<guid>http://www.theheart.org/article/1015489.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1015367.do</link>	<title>Less exposure to cardiovascular risk factors with intensive diabetes intervention: Look AHEAD </title>	<description>		   <![CDATA[ Intensive lifestyle intervention in the management of diabetes produces sustained weight loss and improvements in fitness, as well as improvements in glycemic control, systolic blood pressure, and HDL-cholesterol levels. ]]>		</description>	<pubDate>	lun, 26 oct 2009 10:00:00 EDT	</pubDate>	<guid>http://www.theheart.org/article/1015367.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1015287.do</link>	<title>New MESA data: Pericardial fat a better predictor of CHD than BMI </title>	<description>		   <![CDATA[ Pericardial fat, which is found around the heart, predicts future CHD events and may even be a better predictor of these than conventional obesity measures, such as BMI and waist circumference, a new study of MESA participants shows. ]]>		</description>	<pubDate>	vie, 23 oct 2009 17:00:00 EDT	</pubDate>	<guid>http://www.theheart.org/article/1015287.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1015253.do</link>	<title>NT-proBNP &quot;remarkable predictor&quot; of incident atrial fibrillation</title>	<description>		   <![CDATA[ The fact that elevated baseline NT-proBNP levels predict a diagnosis of AF even 16 years later suggests that peptide elevations precede the onset of arrhythmia, according to the researchers. ]]>		</description>	<pubDate>	vie, 23 oct 2009 16:30:37 EDT	</pubDate>	<guid>http://www.theheart.org/article/1015253.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1015219.do</link>	<title>New model connects low-dose radiation to CVD risk</title>	<description>		   <![CDATA[ Data from Japanese atomic-bomb survivors and people exposed to radiation in their jobs show that even low doses of ionizing radiation may contribute to cardiovascular disease risk. British researchers have created a complex mathematical model to better understand the relationship between radiation exposure and heart disease. ]]>		</description>	<pubDate>	vie, 23 oct 2009 15:30:21 EDT	</pubDate>	<guid>http://www.theheart.org/article/1015219.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1015185.do</link>	<title>Look at absolute event rates when interpreting trial results </title>	<description>		   <![CDATA[ The low event rate in the RECORD trial of rosiglitazone has led some to question the validity of the results.  ]]>		</description>	<pubDate>	vie, 23 oct 2009 13:30:19 EDT	</pubDate>	<guid>http://www.theheart.org/article/1015185.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1015103.do</link>	<title>NHLBI director Nabel named new president of Brigham and Women&#39;s Hospital</title>	<description>		   <![CDATA[ Brigham and Women's/Faulkner Hospitals in Boston names Dr Elizabeth G Nabel as its next president, effective January 1, 2010. ]]>		</description>	<pubDate>	vie, 23 oct 2009 09:15:16 EDT	</pubDate>	<guid>http://www.theheart.org/article/1015103.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1014953.do</link>	<title>GLP-1 analog liraglutide promising in obesity </title>	<description>		   <![CDATA[ A drug originally developed to treat diabetes may have promise as an obesity therapy, a new study shows. Those taking liraglutide, a GLP-1 analog, lost more weight than those on an established obesity medication, orlistat.  ]]>		</description>	<pubDate>	jue, 22 oct 2009 18:30:00 EDT	</pubDate>	<guid>http://www.theheart.org/article/1014953.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1015021.do</link>	<title>HCM transmitted by sperm donation: A case report</title>	<description>		   <![CDATA[ The donor, who was later shown to be affected by a novel beta-myosin heavy-chain mutation that causes HCM, is responsible for at least nine children known to be genetically affected with HCM. ]]>		</description>	<pubDate>	jue, 22 oct 2009 15:45:36 EDT	</pubDate>	<guid>http://www.theheart.org/article/1015021.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1014997.do</link>	<title>Glucose lowering in type 2 diabetes to prevent CVD remains controversial but still important</title>	<description>		   <![CDATA[ Although the case for intensive glucose lowering in diabetic patients to prevent CVD is not straightforward, glucose control is still important for other reasons, and blood pressure and lipid control should not be neglected, according to debaters at a diabetes meeting.   ]]>		</description>	<pubDate>	jue, 22 oct 2009 14:45:51 EDT	</pubDate>	<guid>http://www.theheart.org/article/1014997.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1014853.do</link>	<title>Simple cooling methods improve neurologic outcomes after cardiac arrest, new review confirms</title>	<description>		   <![CDATA[  A new literature review confirms that conventional cooling methods work safely to improve survival and reduce brain damage after cardiac arrest.  ]]>		</description>	<pubDate>	jue, 22 oct 2009 11:00:03 EDT	</pubDate>	<guid>http://www.theheart.org/article/1014853.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1014799.do</link>	<title>New analyses from ECASS 3 support use of tPA up to 4.5 hours after stroke</title>	<description>		   <![CDATA[ Investigators show benefits of thrombolysis after stroke across a variety of subgroups; although not all end points reached statistical significance, trends favored treatment with tPA. The message, though, remains to treat as soon as possible, they say. ]]>		</description>	<pubDate>	jue, 22 oct 2009 08:30:55 EDT	</pubDate>	<guid>http://www.theheart.org/article/1014799.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1014703.do</link>	<title>Iloprost prevents contrast-induced nephropathy in high-risk patients undergoing coronary intervention </title>	<description>		   <![CDATA[ Intravenously administered iloprost, a prostacyclin analog, may help prevent contrast-induced nephropathy in patients with renal dysfunction undergoing coronary procedures, a new pilot study suggests.  ]]>		</description>	<pubDate>	mié, 21 oct 2009 13:00:34 EDT	</pubDate>	<guid>http://www.theheart.org/article/1014703.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1014607.do</link>	<title>Current risk equations may overestimate CVD risk in diabetic patients </title>	<description>		   <![CDATA[ Researchers using different international databases report that the Framingham and UKPDS risk equations overestimate the probability of CV events in diabetic patients.  ]]>		</description>	<pubDate>	mié, 21 oct 2009 10:00:31 EDT	</pubDate>	<guid>http://www.theheart.org/article/1014607.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1014445.do</link>	<title>Cardiovascular disease increases risk of hip fracture </title>	<description>		   <![CDATA[ Swedish researchers have confirmed a link between stroke and subsequent hip fracture in older people and identified for the first time that a diagnosis of heart failure also increases the risk for this fracture. They also identify a large genetic component to this association, via their use of a twin registry. ]]>		</description>	<pubDate>	mar, 20 oct 2009 16:00:00 EDT	</pubDate>	<guid>http://www.theheart.org/article/1014445.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1014201.do</link>	<title>Just one-third of heart-failure patients receive aldosterone antagonists</title>	<description>		   <![CDATA[ Just one-third of hospitalized HF patients who meet the criteria for an aldosterone antagonist receive the drugs upon discharge. On the plus side, few patients with contraindications are prescribed the medication. ]]>		</description>	<pubDate>	mar, 20 oct 2009 16:00:00 EDT	</pubDate>	<guid>http://www.theheart.org/article/1014201.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1014385.do</link>	<title>Omega-3s no help to SSRI-treated CHD patients</title>	<description>		   <![CDATA[ The researchers suggest further study is still needed, as it is unclear whether higher doses of omega-3 fatty acids or setraline, longer treatment, or a different ratio of EPA to DHA would produce favorable results. ]]>		</description>	<pubDate>	mar, 20 oct 2009 16:00:00 EDT	</pubDate>	<guid>http://www.theheart.org/article/1014385.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1014363.do</link>	<title>Data from 1.23 million patients confirms warfarin increases mortality in trauma patients</title>	<description>		   <![CDATA[ Warfarin use is rising in both older and younger patients. How much does the anticoagulant contribute to the risk of traumatic injuries?  ]]>		</description>	<pubDate>	mar, 20 oct 2009 13:45:55 EDT	</pubDate>	<guid>http://www.theheart.org/article/1014363.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1014307.do</link>	<title>Thiazolidinediones have a role for appropriate diabetic patients</title>	<description>		   <![CDATA[ After 10 years of clinical use of TZDs, "we are still at the beginning," and randomized controlled trials shed light on their use in appropriate diabetic patients, speakers at a diabetes symposium reported.  ]]>		</description>	<pubDate>	mar, 20 oct 2009 12:45:38 EDT	</pubDate>	<guid>http://www.theheart.org/article/1014307.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1014283.do</link>	<title>Statin drugs lower costs and complications of aortic surgery</title>	<description>		   <![CDATA[ There are significant cost savings with statin therapy before abdominal aortic aneurysm repair, and the complication rate is less than half that of patients who do not receive preop statins. ]]>		</description>	<pubDate>	mar, 20 oct 2009 11:30:57 EDT	</pubDate>	<guid>http://www.theheart.org/article/1014283.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1014153.do</link>	<title>ACE inhibitors of benefit in ischemic heart disease patients with preserved LV function </title>	<description>		   <![CDATA[ Patients with ischemic heart disease and preserved LV function on standard therapy will gain additional benefit from taking ACE inhibitors, a new review concludes. The same cannot be said for ARBs, a drug class for which the evidence is much weaker, but these are a good substitute in those who cannot tolerate ACE inhibitors, the authors say.  ]]>		</description>	<pubDate>	lun, 19 oct 2009 17:00:00 EDT	</pubDate>	<guid>http://www.theheart.org/article/1014153.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1014115.do</link>	<title>Expanded indication for telmisartan</title>	<description>		   <![CDATA[ The drug can now be used to reduce the risk of MI, stroke, or death from cardiovascular causes in patients 55 years of age or older who are intolerant to ACE inhibitors but at high risk for cardiovascular events. ]]>		</description>	<pubDate>	lun, 19 oct 2009 13:30:16 EDT	</pubDate>	<guid>http://www.theheart.org/article/1014115.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1014027.do</link>	<title>TYCOON: One year of dual-antiplatelet therapy with DES isn&#39;t enough</title>	<description>		   <![CDATA[ New results from an Italian registry reopen the question of how long drug-eluting stent recipients should stay on a dual antiplatelet regimen to prevent late thrombosis.  ]]>		</description>	<pubDate>	lun, 19 oct 2009 12:45:34 EDT	</pubDate>	<guid>http://www.theheart.org/article/1014027.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1013927.do</link>	<title>Transfusion in acute HF: No extra mortality risk </title>	<description>		   <![CDATA[ Blood transfusions for anemia in acute decompensated heart failure don't exacerbate outcomes, as may happen in some ACS cases, suggests a one-year experience of hospitals in Israel. On the contrary . . .   ]]>		</description>	<pubDate>	lun, 19 oct 2009 11:00:10 EDT	</pubDate>	<guid>http://www.theheart.org/article/1013927.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1013811.do</link>	<title>Rosuvastatin cleared for pediatric FH</title>	<description>		   <![CDATA[ The FDA has approved rosuvastatin for use in children aged 10 to 17 years old with familial hypercholesterolemia. ]]>		</description>	<pubDate>	vie, 16 oct 2009 16:30:01 EDT	</pubDate>	<guid>http://www.theheart.org/article/1013811.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1013773.do</link>	<title>Smoking bans reduce the risk of acute coronary events: IOM report </title>	<description>		   <![CDATA[ IOM report confirms the cardiovascular benefit of implementing a ban on smoking in public places. The reduction in acute MI, anywhere from 6% to 47%, typically occurs quickly, often within 12 months of the ban. ]]>		</description>	<pubDate>	vie, 16 oct 2009 16:00:09 EDT	</pubDate>	<guid>http://www.theheart.org/article/1013773.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1013593.do</link>	<title>Zero CAC score not 100% reassuring in those presenting to ER with chest pain</title>	<description>		   <![CDATA[ In those presenting to the ER with chest pain, a prior zero calcium score cannot completely rule out a coronary obstruction, a new analysis of the MESA study has shown. This is likely due to the presence of soft plaques not detected by calcium screening, the researchers say. ]]>		</description>	<pubDate>	vie, 16 oct 2009 12:45:08 EDT	</pubDate>	<guid>http://www.theheart.org/article/1013593.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1013515.do</link>	<title>No link seen between heart failure and coffee intake</title>	<description>		   <![CDATA[ With few studies in the literature specifically looking at the issue, a prospective, population-based study in Sweden has found no significant rise or fall in risk of heart-failure hospitalization or death at increasing levels of coffee intake.    ]]>		</description>	<pubDate>	vie, 16 oct 2009 10:15:02 EDT	</pubDate>	<guid>http://www.theheart.org/article/1013515.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1013467.do</link>	<title>Can statins prevent and treat infection?</title>	<description>		   <![CDATA[ Results from a new meta-analysis show the pleiotropic effects of statins are useful in the treatment and prevention of different infections, including bacteremia, pneumonia, and sepsis. ]]>		</description>	<pubDate>	jue, 15 oct 2009 14:45:36 EDT	</pubDate>	<guid>http://www.theheart.org/article/1013467.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1013433.do</link>	<title>Endovascular repair of aortic aneurysm reduces short-term mortality</title>	<description>		   <![CDATA[ The OVER study of abdominal aortic aneurysm shows that endovascular grafting has a lower mortality rate at 30 days than traditional open surgery. ]]>		</description>	<pubDate>	jue, 15 oct 2009 14:15:51 EDT	</pubDate>	<guid>http://www.theheart.org/article/1013433.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1013409.do</link>	<title>Racial background woefully underreported in CV trials </title>	<description>		   <![CDATA[ Two-thirds of the 156 trials considered by the AHA in preparing a recent guideline failed to even record the ethnic backgrounds of participants, a new study has found. The researchers call for the reporting of race/ethnicity to be mandatory in all clinical trials, and they suggest medical journals should enforce this policy.  ]]>		</description>	<pubDate>	jue, 15 oct 2009 13:15:10 EDT	</pubDate>	<guid>http://www.theheart.org/article/1013409.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1013221.do</link>	<title>New COI disclosure form for all ICMJE journals</title>	<description>		   <![CDATA[ The International Committee of Medical Journal Editors has adopted a new uniform disclosure form for reporting conflicts of interest. ]]>		</description>	<pubDate>	mié, 14 oct 2009 15:15:57 EDT	</pubDate>	<guid>http://www.theheart.org/article/1013221.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1013165.do</link>	<title>Expert council focuses on left main PCI: Guideline changes suggested</title>	<description>		   <![CDATA[ The group argues that the data are substantive enough for left main PCI to be a class IIb indication or even a class IIa indication in selected patients without coexisting multivessel disease. In contrast, the current ACC/AHA guidelines make left main PCI a class III indication unless patients are ineligible for CABG surgery.  ]]>		</description>	<pubDate>	mié, 14 oct 2009 14:45:22 EDT	</pubDate>	<guid>http://www.theheart.org/article/1013165.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1013007.do</link>	<title>A fish tale with merit: Omega-3 PUFAs underrated for heart failure </title>	<description>		   <![CDATA[ Are the data not shouting loud enough, or is cardiology hard of herring? Omega-3 fatty acids may have only a modest treatment effect in heart failure, but they've performed swimmingly in randomized and observational studies considering how few new HF drugs have been reeled in lately.  ]]>		</description>	<pubDate>	mié, 14 oct 2009 12:30:27 EDT	</pubDate>	<guid>http://www.theheart.org/article/1013007.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1012925.do</link>	<title>Scripps starts routine genetic testing for clopidogrel responsiveness </title>	<description>		   <![CDATA[ Scripps Health has announced that it is now offering patients undergoing elective stenting a test for the gene variants associated with an inability to convert clopidogrel to its active metabolite so that antiplatelet therapy can be individualized. ]]>		</description>	<pubDate>	mié, 14 oct 2009 11:00:05 EDT	</pubDate>	<guid>http://www.theheart.org/article/1012925.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1012577.do</link>	<title>Hospital efficiency gauged by resource use vs outcomes </title>	<description>		   <![CDATA[ An analysis of Medicare data from heart-failure patients at six California hospitals challenges the notion advanced by some studies that hospital efficiency can be measured by looking back at resource use on behalf of patients who ultimately died.   ]]>		</description>	<pubDate>	mar, 13 oct 2009 16:00:00 EDT	</pubDate>	<guid>http://www.theheart.org/article/1012577.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1012809.do</link>	<title>Diuretics effective as second-line therapy for hypertension </title>	<description>		   <![CDATA[ Diuretics, especially hydrochlorothiazide, are as effective when given as second-line therapy for high blood pressure as they are when used as initial treatment, according to the first review to look at this issue.  ]]>		</description>	<pubDate>	mar, 13 oct 2009 12:00:48 EDT	</pubDate>	<guid>http://www.theheart.org/article/1012809.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1012533.do</link>	<title>Hopes build for natriuretic-peptide risk stratification before noncardiac surgery </title>	<description>		   <![CDATA[ Could a preoperative blood assay take the place of imaging studies or other more costly assessments of cardiovascular risk? A meta-analysis suggests yes. A massive randomized trial is looking into it now.   ]]>		</description>	<pubDate>	mar, 13 oct 2009 10:00:10 EDT	</pubDate>	<guid>http://www.theheart.org/article/1012533.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1011519.do</link>	<title>Genetic variant again linked with statin side effects</title>	<description>		   <![CDATA[ Carriers of the <i>SLCO1B1*5 </i>allele are at a twofold increased risk of mild statin-induced side effects, and the majority of these individuals had normal creatine-kinase levels. ]]>		</description>	<pubDate>	lun, 12 oct 2009 17:00:00 EDT	</pubDate>	<guid>http://www.theheart.org/article/1011519.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1012375.do</link>	<title>Glucocorticoids seen to double risk of atrial arrhythmias </title>	<description>		   <![CDATA[ In a case-control study from Denmark, the risk of atrial fibrillation or flutter was significantly increased with current but not previous use of glucocorticoids for chronic obstructive pulmonary disease, rheumatoid arthritis, and other conditions. ]]>		</description>	<pubDate>	lun, 12 oct 2009 16:00:00 EDT	</pubDate>	<guid>http://www.theheart.org/article/1012375.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1012397.do</link>	<title>Vernakalant converts AF to sinus rhythm postsurgery</title>	<description>		   <![CDATA[ The drug, however, is still not yet approved by the Food and Drug Administration. ]]>		</description>	<pubDate>	vie, 09 oct 2009 17:15:03 EDT	</pubDate>	<guid>http://www.theheart.org/article/1012397.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1012275.do</link>	<title>Target HbA1c levels still the subject of much debate, but tailored therapy should be the aim </title>	<description>		   <![CDATA[ Diabetologists are trying to tease out the best message to convey when it comes to target HbA<sub>1c</sub> levels for primary-care physicians and other nonspecialists who might be treating patients with type 2 diabetes.  ]]>		</description>	<pubDate>	vie, 09 oct 2009 16:45:25 EDT	</pubDate>	<guid>http://www.theheart.org/article/1012275.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1012161.do</link>	<title>High adherence to antihypertensive therapy lowers cardiovascular risk</title>	<description>		   <![CDATA[ Newly diagnosed hypertensive individuals who stuck to their antihypertensive therapy had a significantly lower risk of cardiovascular events than low adherers.  ]]>		</description>	<pubDate>	vie, 09 oct 2009 13:30:36 EDT	</pubDate>	<guid>http://www.theheart.org/article/1012161.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1012133.do</link>	<title>EULAR: CV risk management in inflammatory arthritis</title>	<description>		   <![CDATA[ The European League Against Rheumatism has issued 10 recommendations for cardiovascular risk management in patients with rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis. ]]>		</description>	<pubDate>	vie, 09 oct 2009 11:45:12 EDT	</pubDate>	<guid>http://www.theheart.org/article/1012133.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1012103.do</link>	<title>FDA clears colesevelam for FH in kids</title>	<description>		   <![CDATA[ The FDA has approved an expanded indication for colesevelam tablets and a new powder for oral suspension as an adjunct to diet and exercise to reduce LDL-C levels in boys and postmenarchal girls aged 10 to 17 years with heterozygous familial hypercholesterolemia. ]]>		</description>	<pubDate>	vie, 09 oct 2009 11:00:39 EDT	</pubDate>	<guid>http://www.theheart.org/article/1012103.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1012007.do</link>	<title>Coronary thrombosis—the culprit is not just plaque rupture </title>	<description>		   <![CDATA[ Clots derived from a different source&#151;erosions of the arterial wall&#151;may be an important cause of MI and sudden death, particularly in younger women, who may need a different approach to treatment, new research suggests.  ]]>		</description>	<pubDate>	jue, 08 oct 2009 17:45:48 EDT	</pubDate>	<guid>http://www.theheart.org/article/1012007.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1011961.do</link>	<title>New joint statement streamlines definition of metabolic syndrome</title>	<description>		   <![CDATA[ The statement from the International Diabetes Federation, the National Heart, Lung, and Blood Institute, and the American Heart Association, among others, formalizes the definition of the metabolic disorder with the hope of eliminating some of the confusion regarding how to identify patients with the syndrome. ]]>		</description>	<pubDate>	jue, 08 oct 2009 16:45:46 EDT	</pubDate>	<guid>http://www.theheart.org/article/1011961.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1011883.do</link>	<title>New review confirms homocysteine lowering does not prevent CVD events</title>	<description>		   <![CDATA[ The latest review to look at the effects of homocysteine lowering with vitamin-B supplementation has come to much the same conclusions as most other studies and analyses in this field.  ]]>		</description>	<pubDate>	jue, 08 oct 2009 15:30:45 EDT	</pubDate>	<guid>http://www.theheart.org/article/1011883.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1011331.do</link>	<title>Experts debate bariatric surgery as a cure for diabetes </title>	<description>		   <![CDATA[ Under the some-say-misguided term "metabolic" surgery, gastric bypass is now being used in some instances to treat diabetics who are not considered morbidly obese. Experts say the mostly circumstantial evidence on this is intriguing, but prospective data are desperately needed in this group of patients. ]]>		</description>	<pubDate>	jue, 08 oct 2009 13:15:54 EDT	</pubDate>	<guid>http://www.theheart.org/article/1011331.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1011187.do</link>	<title>IRIS confirms: No survival gains from early post-MI primary-prevention ICDs</title>	<description>		   <![CDATA[ Defibrillators implanted within a month of acute MI may prevent sudden cardiac deaths, but they don't reduce overall mortality, according to a trial that supports current guidelines based primarily on the smaller 2004 trial DINAMIT.   ]]>		</description>	<pubDate>	mié, 07 oct 2009 17:00:00 EDT	</pubDate>	<guid>http://www.theheart.org/article/1011187.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1011211.do</link>	<title>Elizabeth Taylor tweets about experimental MitraClip procedure </title>	<description>		   <![CDATA[ The MitraClip will likely go before the FDA early next year, meaning that Taylor's experience with the device will form a small (and anonymous) part of the FDA's deliberations. ]]>		</description>	<pubDate>	mié, 07 oct 2009 16:00:04 EDT	</pubDate>	<guid>http://www.theheart.org/article/1011211.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1010925.do</link>	<title>Lupus anticoagulant a major risk factor for stroke and MI in young women</title>	<description>		   <![CDATA[ Results of the RATIO study suggest lupus anticoagulant, but not anticardiolipin or antiprothrombin antibodies, is associated with increased stroke risk and to a lesser extent MI.  ]]>		</description>	<pubDate>	mié, 07 oct 2009 10:00:40 EDT	</pubDate>	<guid>http://www.theheart.org/article/1010925.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1010897.do</link>	<title>Mercury/blood-pressure link should guide fish choices </title>	<description>		   <![CDATA[ An association seen between mercury levels and blood pressure, even after considering omega-3s and selenium, has researchers warning about the need to weigh the risks and benefits of fish consumption and to steer clear of bigger predators.  ]]>		</description>	<pubDate>	mar, 06 oct 2009 16:45:03 EDT	</pubDate>	<guid>http://www.theheart.org/article/1010897.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1010873.do</link>	<title>Counseling and education fail to reduce prehospital delays in ACS</title>	<description>		   <![CDATA[ Even among patients with documented ischemic heart disease, an intensive program of education and counseling about the importance of seeking treatment quickly does not lead to reductions in prehospital delays or increased ambulance use among those experiencing the signs and symptoms of an ACS, a new study shows. ]]>		</description>	<pubDate>	mar, 06 oct 2009 16:00:00 EDT	</pubDate>	<guid>http://www.theheart.org/article/1010873.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1010849.do</link>	<title>Incidental findings on cardiac CT costly and rarely clinically significant</title>	<description>		   <![CDATA[ Among nearly 1000 consecutive patients who underwent cardiac CT, 41% had noncardiac incidental findings, but just 1.2% of these were clinically significant. While another 7% were "indeterminate," none of these inconclusive findings became clinically significant during follow-up. ]]>		</description>	<pubDate>	mar, 06 oct 2009 15:15:01 EDT	</pubDate>	<guid>http://www.theheart.org/article/1010849.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1010825.do</link>	<title>China death toll due to hypertension worse than predicted </title>	<description>		   <![CDATA[ The first prospective study using real data to inform the number of people suffering from and dying due to high blood pressure in China finds the problem is much worse than previously thought. A number of initiatives are planned to try to tackle this crisis. ]]>		</description>	<pubDate>	mar, 06 oct 2009 14:15:24 EDT	</pubDate>	<guid>http://www.theheart.org/article/1010825.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1010799.do</link>	<title>Thiazolidinediones once again linked to fracture risk</title>	<description>		   <![CDATA[ Risk appeared to be similar in men and women, with exposure to either rosiglitazone or pioglitazone, and across a range of fracture sites. The longer the duration of exposure to the drugs, the greater the risk.  ]]>		</description>	<pubDate>	mar, 06 oct 2009 12:30:18 EDT	</pubDate>	<guid>http://www.theheart.org/article/1010799.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1010721.do</link>	<title>Simple, fixed-dose drug bundle may lower MI and stroke risk</title>	<description>		   <![CDATA[ A bundle of medium doses of a statin and an ACE inhibitor appears to lower CV risk in high-risk individuals, an observational study suggests, but critics caution that these are early days.  ]]>		</description>	<pubDate>	mar, 06 oct 2009 10:15:41 EDT	</pubDate>	<guid>http://www.theheart.org/article/1010721.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1010685.do</link>	<title>Acute heart-failure prediction model blends clinical gestalt with natriuretic peptides</title>	<description>		   <![CDATA[ Its developers say the prediction model for guiding management of patients presenting with dyspnea can make a difference when clinicians aren't sure about the diagnosis based on clinical signs. An editorial takes issue.   ]]>		</description>	<pubDate>	lun, 05 oct 2009 17:00:00 EDT	</pubDate>	<guid>http://www.theheart.org/article/1010685.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1010661.do</link>	<title>20 000-patient DAPT clinical trial starts enrolling with eight industry sponsors on board </title>	<description>		   <![CDATA[ The trial, rumored to cost more than $100 million, is a first for collaboration: eight drug and device companies are backing the trial, along with the FDA. The study is powered to detect a difference in stent thrombosis and major adverse events between patients taking 12 or 30 months of aspirin plus clopidogrel or prasugrel. ]]>		</description>	<pubDate>	lun, 05 oct 2009 16:45:09 EDT	</pubDate>	<guid>http://www.theheart.org/article/1010661.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1010617.do</link>	<title>Philips recalls thousands of AEDs  </title>	<description>		   <![CDATA[ The automatic external defibrillators were distributed by Philips Medical and Laerdal Medical with model numbers M3860A, M3861A, M3840A, and M3841A.   ]]>		</description>	<pubDate>	lun, 05 oct 2009 14:00:59 EDT	</pubDate>	<guid>http://www.theheart.org/article/1010617.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1010567.do</link>	<title>Hypoglycemia associated with increased risk of MI among US veterans with diabetes </title>	<description>		   <![CDATA[ Close attention should be paid to diabetes patients who experience an episode of hypoglycemia, because a new case-control study suggests a 65% increased risk of MI in the immediate two-week aftermath of such an event. Doctors should tailor diabetes therapies to minimize the risk of hypoglycemia occurring, say the researchers.  ]]>		</description>	<pubDate>	lun, 05 oct 2009 13:45:19 EDT	</pubDate>	<guid>http://www.theheart.org/article/1010567.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1010343.do</link>	<title>Next up: Drug-eluting stents for erectile dysfunction </title>	<description>		   <![CDATA[ In what may be the first clinical trial to test a DES in the pudendal artery, investigators at nine sites are looking at whether pudendal stenting is safe and effective in men who have failed PDE-5 inhibitors.  ]]>		</description>	<pubDate>	vie, 02 oct 2009 17:45:26 EDT	</pubDate>	<guid>http://www.theheart.org/article/1010343.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1010307.do</link>	<title>Stroke reduction with dronedarone shown in post hoc analysis</title>	<description>		   <![CDATA[ Investigators say that although the analysis raises the possibility that a drug with antiarrhythmic activity could reduce the risk of stroke, dronedarone is not a replacement for oral anticoagulant therapy or a treatment for stroke prevention. ]]>		</description>	<pubDate>	vie, 02 oct 2009 17:15:19 EDT	</pubDate>	<guid>http://www.theheart.org/article/1010307.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1010255.do</link>	<title>Insulin glargine and cancer: Association, no causal link </title>	<description>		   <![CDATA[ That was the conclusion of a recent panel of experts, perhaps alleviating concerns raised by several recent studies.   ]]>		</description>	<pubDate>	vie, 02 oct 2009 15:00:18 EDT	</pubDate>	<guid>http://www.theheart.org/article/1010255.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1010173.do</link>	<title>New heparin standards reduce potency of drug 10%</title>	<description>		   <![CDATA[ The Food and Drug Administration is asking clinicians to be aware of the change, particularly in settings where an immediate anticoagulant effect is clinically important. ]]>		</description>	<pubDate>	vie, 02 oct 2009 12:30:34 EDT	</pubDate>	<guid>http://www.theheart.org/article/1010173.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1010093.do</link>	<title>New &quot;principles&quot; on authorship and COI from PhRMA get mixed response</title>	<description>		   <![CDATA[  The "Principles on Conduct of Clinical Trials and Communication of Clinical Trial Results" echo recent standards set by medical journal editors, but some observers say the document, which has no penalty component, lacks real teeth. ]]>		</description>	<pubDate>	vie, 02 oct 2009 12:00:10 EDT	</pubDate>	<guid>http://www.theheart.org/article/1010093.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1009961.do</link>	<title>Wealthy Americans more likely to benefit from statin therapy than poor</title>	<description>		   <![CDATA[ In the past 30 years, wealthier Americans, who were once more likely to have high total- and LDL-cholesterol levels than poorer individuals, now have a significantly better lipid profile. Statins, say researchers, may have contributed to the expanding social disparities in cardiovascular risk.  ]]>		</description>	<pubDate>	jue, 01 oct 2009 16:45:51 EDT	</pubDate>	<guid>http://www.theheart.org/article/1009961.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1009907.do</link>	<title>HORIZONS analysis: 600-mg clopidogrel load preferable in primary PCI</title>	<description>		   <![CDATA[ The higher dose was associated with a reduced rate of ischemic events without an increase in bleeding in patients with STEMI undergoing primary PCI. ]]>		</description>	<pubDate>	jue, 01 oct 2009 16:00:46 EDT	</pubDate>	<guid>http://www.theheart.org/article/1009907.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1009753.do</link>	<title>REVERSE, MADIT-CRT make case for extending CRT to mild heart failure: Should guidelines change?</title>	<description>		   <![CDATA[ Now in print after having been presented at meetings, the REVERSE randomized trial's European-cohort two-year results are consistent with the recently published, much larger MADIT-CRT trial in showing both clinical and LV structural benefits from resynchronization therapy in patients with NYHA class 1-2 heart failure. ]]>		</description>	<pubDate>	jue, 01 oct 2009 10:30:49 EDT	</pubDate>	<guid>http://www.theheart.org/article/1009753.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1009621.do</link>	<title>Time to act: Cardiologists, diabetes docs, and psychiatrists urged to work together to tackle CVD in the mentally ill </title>	<description>		   <![CDATA[ Doctors from across the specialties of cardiology, diabetes, and psychiatry are being urged to collaborate to improve care for the mentally ill, who are more likely to die from cardiovascular disease than any other cause. ]]>		</description>	<pubDate>	mié, 30 sep 2009 14:00:04 EDT	</pubDate>	<guid>http://www.theheart.org/article/1009621.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1009465.do</link>	<title>Pump may not be the culprit in &quot;pump head&quot; after CABG</title>	<description>		   <![CDATA[ The decline in cognitive function that is often seen after CABG may not be related to the use of cardiopulmonary bypass or to embolic debris in the bloodstream from the bypass pump, Chinese researchers say. ]]>		</description>	<pubDate>	mié, 30 sep 2009 11:15:57 EDT	</pubDate>	<guid>http://www.theheart.org/article/1009465.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1009413.do</link>	<title>Only one in eight strokes heralded by TIA</title>	<description>		   <![CDATA[ A new study finds only about one in eight strokes are preceded by transient ischemic attack. The results underline the need for a broader approach to primary prevention, researchers say.   ]]>		</description>	<pubDate>	mié, 30 sep 2009 10:00:41 EDT	</pubDate>	<guid>http://www.theheart.org/article/1009413.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1009297.do</link>	<title>Kissing-balloon dilatation of side branch not needed with one-stent bifurcation approach</title>	<description>		   <![CDATA[ With the one-stent technique for the treatment of bifurcation lesions, the use of routine kissing-balloon dilatation of the side branch does not improve six-month clinical outcomes. ]]>		</description>	<pubDate>	mar, 29 sep 2009 16:15:30 EDT	</pubDate>	<guid>http://www.theheart.org/article/1009297.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1009135.do</link>	<title>Doctor-led &quot;hospital-at-home&quot; care subs for hospitalization in acute heart failure</title>	<description>		   <![CDATA[ They lived just as long, but in a small randomized trial, patients with acute decompensated heart failure who received hospital-quality care in their homes as an alternative to hospital admission after presentation to the emergency department benefited in ways missed by those managed as inpatients in the traditional manner.  ]]>		</description>	<pubDate>	mar, 29 sep 2009 12:00:05 EDT	</pubDate>	<guid>http://www.theheart.org/article/1009135.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1009035.do</link>	<title>BCIS-1 trial: &quot;Bailout&quot; intra-aortic balloon pump beats elective use in low EF/high-risk patients</title>	<description>		   <![CDATA[ The study provides an important answer to a question that has divided some interventionalists. Those who "swear" by IABP use for all high-risk, low-EF patients should rethink their practice. In hypotensive patients and those with cardiogenic shock, IABPs play a key role.  ]]>		</description>	<pubDate>	mar, 29 sep 2009 10:45:47 EDT	</pubDate>	<guid>http://www.theheart.org/article/1009035.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1008965.do</link>	<title>FAUST: Ultrasound guidance improves femoral access in cases of high bifurcation, reduces risk of complication</title>	<description>		   <![CDATA[ <b><i>CORRECTED </i></b><i>// </i>A study has found that although ultrasound imaging doesn't seem to improve upon the overall success rate of fluoroscopy-assisted femoral-access PCI, it does seem to facilitate the procedure, reducing the risk of access complications by 59% and doubling the first-pass success rate. ]]>		</description>	<pubDate>	mar, 29 sep 2009 09:45:25 EDT	</pubDate>	<guid>http://www.theheart.org/article/1008965.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1008859.do</link>	<title>Diabetes: An independent risk factor for AF </title>	<description>		   <![CDATA[ Atrial fibrillation was more likely to develop in diabetics than in nondiabetics in a new observational study, and the link was particularly strong in women.  ]]>		</description>	<pubDate>	mar, 29 sep 2009 00:00:23 EDT	</pubDate>	<guid>http://www.theheart.org/article/1008859.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1008905.do</link>	<title>Early statin therapy in ACS: What&#39;s the level of evidence?</title>	<description>		   <![CDATA[ The use of high-dose statin therapy early in the course of acute coronary syndrome currently has the highest possible (class IA) recommendation in US guidelines, but a group of experts argues that this is inaccurate based on current evidence. However, they stress, they are not saying statins should not be used in this indication. ]]>		</description>	<pubDate>	lun, 28 sep 2009 17:00:00 EDT	</pubDate>	<guid>http://www.theheart.org/article/1008905.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1008719.do</link>	<title>New biomarker, galectin-3, shows risk-stratification potential in chronic heart failure </title>	<description>		   <![CDATA[ The proposed biomarker, which seems to apparently play a role in the progression of cardiomyopathy and heart failure, predicted mortality or HF hospitalization in a post hoc analysis from the already published COACH randomized trial. ]]>		</description>	<pubDate>	lun, 28 sep 2009 15:00:18 EDT	</pubDate>	<guid>http://www.theheart.org/article/1008719.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1008623.do</link>	<title>CHARISMA Genomics Substudy links loss-of-function allele and bleeding</title>	<description>		   <![CDATA[ Patients who are homozygous for the CYP2C19*2 allele are at increased risk of ischemia but less likely to bleed. Routine genotyping for the variant still isn't recommended. ]]>		</description>	<pubDate>	lun, 28 sep 2009 14:15:11 EDT	</pubDate>	<guid>http://www.theheart.org/article/1008623.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1008447.do</link>	<title>Sitagliptin linked to acute pancreatitis, FDA warns</title>	<description>		   <![CDATA[ The FDA is revising prescribing information for sitagliptin and sitagliptin/metformin after cases of acute pancreatitis, some severe, surfaced in postmarketing reports. ]]>		</description>	<pubDate>	lun, 28 sep 2009 13:00:51 EDT	</pubDate>	<guid>http://www.theheart.org/article/1008447.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1008381.do</link>	<title>Skin lesions from heparin more common than thought </title>	<description>		   <![CDATA[ A new prospective study has found the incidence of heparin-induced skin lesions to be around 7.5%. Women, the obese, and those on heparin therapy for longest are most at risk.  ]]>		</description>	<pubDate>	lun, 28 sep 2009 12:00:00 EDT	</pubDate>	<guid>http://www.theheart.org/article/1008381.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1008283.do</link>	<title>No relationship between significant carotid stenosis and stroke after cardiac surgery</title>	<description>		   <![CDATA[ A large single-center retrospective study finds no association between carotid stenosis and stroke after cardiac surgery. The findings may finally answer the question of whether carotid endarterectomy prior to or during heart surgery provides any benefit.  ]]>		</description>	<pubDate>	lun, 28 sep 2009 10:00:08 EDT	</pubDate>	<guid>http://www.theheart.org/article/1008283.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1008155.do</link>	<title>Reduced bleeding and comparable stent thrombosis with DES and bare-metal stents: HORIZONS-AMI at two years</title>	<description>		   <![CDATA[ Two-year data showed significant reductions in bleeding and cardiac mortality in patients treated with bivalirudin when compared with those treated with heparin plus a GP IIb/IIIa inhibitor. In the stent arm of the trial, researchers showed that stent thrombosis rates were equivalent between DES and bare-metal stents, although both rates were high, at 4.1%.  ]]>		</description>	<pubDate>	vie, 25 sep 2009 17:55:17 EDT	</pubDate>	<guid>http://www.theheart.org/article/1008155.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1008053.do</link>	<title>PLATO-Invasive: Impressive ticagrelor results mirror overall trial findings </title>	<description>		   <![CDATA[ The prespecified subset analysis helps clarify the performance of the drug in patients managed invasively, including adding new insights into its benefits over both the 300-mg and 600-mg loading doses of clopidogrel.  ]]>		</description>	<pubDate>	vie, 25 sep 2009 17:30:21 EDT	</pubDate>	<guid>http://www.theheart.org/article/1008053.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1007977.do</link>	<title>Hormonal therapies for prostate cancer increase risk of heart disease  </title>	<description>		   <![CDATA[ A huge study of Swedish data shows an increased risk of all types of cardiovascular disease in men taking hormonal therapies for prostate cancer.  ]]>		</description>	<pubDate>	vie, 25 sep 2009 16:30:12 EDT	</pubDate>	<guid>http://www.theheart.org/article/1007977.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1007873.do</link>	<title>PROSPECT: Vulnerable lesions lead to unstable angina rather than MI or death</title>	<description>		   <![CDATA[ After successful PCI, 20% of patients go on to have a MACE at three years and 12% of patients develop events from nonculprit lesions. PROSPECT investigators say, however, that events from these nonculprit lesions are more likely to be unstable angina or progressive angina, rather than harder events such as MI or cardiac death. ]]>		</description>	<pubDate>	vie, 25 sep 2009 14:15:11 EDT	</pubDate>	<guid>http://www.theheart.org/article/1007873.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1007609.do</link>	<title>Tributes to Helmut Drexler, who has died at age 58</title>	<description>		   <![CDATA[ Dr Helmut Drexler, who suffered a sudden cardiac death earlier this month, was at the height of his career and will be sorely missed, friends told <b>heart</b><b><i>wire</i></b>.  ]]>		</description>	<pubDate>	vie, 25 sep 2009 11:45:46 EDT	</pubDate>	<guid>http://www.theheart.org/article/1007609.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1007461.do</link>	<title>BNP-boosting gene variant hints at possible screening, cardioprotective roles  </title>	<description>		   <![CDATA[ A single-nucleotide polymorphism associated with chronically raised natriuretic-peptide levels is common enough to potentially influence interpretation of BNP and NT-proBNP assays under some circumstances, researchers say; there is increasing evidence that the gene variant may enhance survival in some patient groups. ]]>		</description>	<pubDate>	vie, 25 sep 2009 10:45:02 EDT	</pubDate>	<guid>http://www.theheart.org/article/1007461.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1007305.do</link>	<title>COMPARE: &quot;Real-world&quot; randomized trial favors Xience V over Taxus Liberté </title>	<description>		   <![CDATA[ COMPARE is the second of two large randomized controlled trials comparing a Taxus stent with Xience V to show a clear benefit of the newer stent. ]]>		</description>	<pubDate>	vie, 25 sep 2009 08:30:19 EDT	</pubDate>	<guid>http://www.theheart.org/article/1007305.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1007269.do</link>	<title>Doubling dose of clopidogrel benefits STEMI patients without risk of bleeding</title>	<description>		   <![CDATA[ Doubling the dose of clopidogrel reduced the risk of MI and stent thrombosis in STEMI patients without increasing the risk of bleeding. The benefit extended to patients who received a bare-metal stent or a drug-eluting stent. ]]>		</description>	<pubDate>	jue, 24 sep 2009 17:45:49 EDT	</pubDate>	<guid>http://www.theheart.org/article/1007269.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1007145.do</link>	<title>COGENT: No CV events but significant GI benefits of PPI omeprazole</title>	<description>		   <![CDATA[ The randomized controlled trial results should put a stop to alarmist headlines about PPIs blunting efficacy of antiplatelet drugs, experts say. By withholding PPIs, physicians are doing more harm than good, the results suggest. ]]>		</description>	<pubDate>	jue, 24 sep 2009 16:30:07 EDT	</pubDate>	<guid>http://www.theheart.org/article/1007145.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1007049.do</link>	<title>FAME lives on: FFR results durable at two years</title>	<description>		   <![CDATA[ The past few cardiology meetings have included data on the FAME study, and TCT 2009 was no exception. Investigators showed that the one-year and 18-month results were durable out to two years, although some researchers would like to see the study replicated to conclusively prove the added value of fractional flow reserve testing. ]]>		</description>	<pubDate>	jue, 24 sep 2009 14:45:38 EDT	</pubDate>	<guid>http://www.theheart.org/article/1007049.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1006911.do</link>	<title>New Canadian lipid guidelines will recommend CRP testing for certain patients </title>	<description>		   <![CDATA[ New Canadian guidelines for the diagnosis and treatment of dyslipidemia and the prevention of cardiovascular disease will recommend the testing of hs-CRP for certain patients, most notably those at intermediate risk. However, the lead author stresses that the majority of patients will not require a CRP test and that recommending and promoting a healthy lifestyle must be the first port-of-call for doctors.  ]]>		</description>	<pubDate>	jue, 24 sep 2009 13:45:07 EDT	</pubDate>	<guid>http://www.theheart.org/article/1006911.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1006629.do</link>	<title>SIRTAX LATE: No differences in MACE for first-generation stents at five years</title>	<description>		   <![CDATA[ After one year, Cypher had lower rates of death, MI, or repeat PCIs than Taxus in the SIRTAX trial. But four years later, investigators say all differences between the two have disappeared, in part due to more late "catch-up" with the Cypher.  ]]>		</description>	<pubDate>	jue, 24 sep 2009 08:30:17 EDT	</pubDate>	<guid>http://www.theheart.org/article/1006629.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1006595.do</link>	<title>Stent sandwich: First-generation stents equal for Cypher in-stent restenosis</title>	<description>		   <![CDATA[ Late lumen loss at one year, the primary end point, was equivalent between the Cypher and Taxus stent at one year among patients with restenosis after initial treatment with the Cypher stent.  ]]>		</description>	<pubDate>	jue, 24 sep 2009 07:45:13 EDT	</pubDate>	<guid>http://www.theheart.org/article/1006595.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1006453.do</link>	<title>SPIRIT IV: Xience V trumps Taxus for clinically driven end points, although diabetic questions linger</title>	<description>		   <![CDATA[ <b><i>UPDATED</i></b> // Rates of target lesion failure were significantly lower for the everolimus-eluting Xience V stent for the trial as a whole. In diabetic patients only, however, no differences were seen between the two stents. ]]>		</description>	<pubDate>	mié, 23 sep 2009 16:15:24 EDT	</pubDate>	<guid>http://www.theheart.org/article/1006453.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1006177.do</link>	<title>Should patients go directly to a PCI-capable hospital? Two studies, different results</title>	<description>		   <![CDATA[ One trial showed that despite a mean treatment delay of 67 minutes, STEMI patients undergoing primary PCI taken first to an emergency department before transfer had equivalent rates of major adverse cardiac events when compared with those who presented directly to a PCI facility. A smaller study showed that taking patients directly to the cardiac center resulted in significantly better survival when compared with patients who were transported to an emergency department. ]]>		</description>	<pubDate>	mié, 23 sep 2009 10:45:51 EDT	</pubDate>	<guid>http://www.theheart.org/article/1006177.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1006131.do</link>	<title>Changing PARTNER: Program tweaks overshadow updates from transcatheter-valve studies</title>	<description>		   <![CDATA[ A packed session of interventionalists eager to hear more about long-term safety and efficacy were caught off-guard by news that a new co-primary end point has been added to cohort B.  ]]>		</description>	<pubDate>	mié, 23 sep 2009 09:15:00 EDT	</pubDate>	<guid>http://www.theheart.org/article/1006131.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1006071.do</link>	<title>Senators question Dr Martin Leon&#39;s financial links to industry</title>	<description>		   <![CDATA[ <b><i>UPDATED</i></b> // The letter, from Sens Herb Kohl and Charles Grassley, states that Leon did not fully disclose much of the money he has received from outside companies.  ]]>		</description>	<pubDate>	mar, 22 sep 2009 17:15:30 EDT	</pubDate>	<guid>http://www.theheart.org/article/1006071.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1006021.do</link>	<title>Enoxaparin cheaper than UFH in STEMI patients undergoing thrombolysis? </title>	<description>		   <![CDATA[ A new analysis of the EXTRACT-TIMI 25 trial concludes that enoxaparin is slightly cheaper in the long term than unfractionated heparin for STEMI patients undergoing thrombolysis. But there are questions as to why 30-day data and not one-year results were used to model long-term cost-effectiveness.  ]]>		</description>	<pubDate>	mar, 22 sep 2009 17:15:18 EDT	</pubDate>	<guid>http://www.theheart.org/article/1006021.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1005959.do</link>	<title>FDA approves aliskiren/valsartan combo for HTN</title>	<description>		   <![CDATA[  ]]>		</description>	<pubDate>	mar, 22 sep 2009 15:15:54 EDT	</pubDate>	<guid>http://www.theheart.org/article/1005959.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1005711.do</link>	<title>Mixed start to planned MARVEL trial of post-MI autologous skeletal-myoblast therapy</title>	<description>		   <![CDATA[ A pilot analysis suggests the cell therapy can improve functional capacity, but amiodarone may be needed to prevent ventricular arrhythmias; its investigators say they plan to switch gears on the remainder of the study. ]]>		</description>	<pubDate>	mar, 22 sep 2009 14:00:42 EDT	</pubDate>	<guid>http://www.theheart.org/article/1005711.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1005755.do</link>	<title>Should left main PCI be a class IIa indication?</title>	<description>		   <![CDATA[ TCT 2009 kicked off with a discussion on revascularization strategies for left main PCI. Interventionalist Dr Paul Teirstein argues the data are sufficient for left main PCI to be a class IIa indication, upgrading it from the current class III recommendation, but surgeon Dr David Taggart says that CABG is still the preferred revascularization option in the majority of left main patients. ]]>		</description>	<pubDate>	mar, 22 sep 2009 13:15:44 EDT	</pubDate>	<guid>http://www.theheart.org/article/1005755.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1005627.do</link>	<title>Three-year SPIRIT III results show enduring edge for Xience V over Taxus </title>	<description>		   <![CDATA[ Three-year target vessel failure remained statistically lower for the everolimus-eluting Xience V stent (which is also marketed as the Promus) than for the paclitaxel-eluting Taxus stent.  ]]>		</description>	<pubDate>	mar, 22 sep 2009 11:45:00 EDT	</pubDate>	<guid>http://www.theheart.org/article/1005627.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1005381.do</link>	<title>ENDEAVOR IV: Revascularization rates similar for Endeavor and Taxus at three years, with Endeavor &quot;pulling ahead&quot; for safety </title>	<description>		   <![CDATA[ Rates of cardiac death and MI actually statistically favor the Endeavor stent at three years, new data show. Stent thrombosis occurred just once after one year for Endeavor, as compared with 11 cases after the one-year mark in the Taxus-treated patients. ]]>		</description>	<pubDate>	mar, 22 sep 2009 09:45:47 EDT	</pubDate>	<guid>http://www.theheart.org/article/1005381.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1005247.do</link>	<title>Flu vaccine may protect against MI </title>	<description>		   <![CDATA[ A protective effect was seen in patients with established cardiovascular disease. Whether vaccination is protective in people with no vascular disease is less clear, a new review suggests.  ]]>		</description>	<pubDate>	lun, 21 sep 2009 18:30:00 EDT	</pubDate>	<guid>http://www.theheart.org/article/1005247.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1005307.do</link>	<title>Upping duration of CPR compressions improves survival</title>	<description>		   <![CDATA[  ]]>		</description>	<pubDate>	lun, 21 sep 2009 17:30:00 EDT	</pubDate>	<guid>http://www.theheart.org/article/1005307.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1005213.do</link>	<title>Further testing and increased costs only for those with high CAC scores: EISNER study</title>	<description>		   <![CDATA[ Patients who undergo coronary artery calcium scans are unlikely to undergo further testing or invasive procedures if the CAC scores are low. The results suggest that CAC might play a role in more selective testing patterns in asymptomatic individuals at risk for cardiovascular disease, say researchers.  ]]>		</description>	<pubDate>	lun, 21 sep 2009 17:00:00 EDT	</pubDate>	<guid>http://www.theheart.org/article/1005213.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1004417.do</link>	<title>Smoking bans cut heart attacks by up to a quarter </title>	<description>		   <![CDATA[ A nationwide smoking ban in the US would prevent up to 150 000 new MIs every year, the authors of a new meta-analysis estimate. They show that similar bans in parts of the US and in other countries have reduced the incidence of MI by almost 20% and that the longer the ban is in place, the greater the benefits seem to be.  ]]>		</description>	<pubDate>	lun, 21 sep 2009 17:00:00 EDT	</pubDate>	<guid>http://www.theheart.org/article/1004417.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1004981.do</link>	<title>Added to diuretics, low-dose dopamine renoprotective in small acute-HF trial</title>	<description>		   <![CDATA[ Better late than never in the age of evidence-based medicine, a randomized test of an established strategy might have confirmed the value of adding dopamine to loop diuretics to allow the latter at reduced, less kidney-damaging dosages.  ]]>		</description>	<pubDate>	lun, 21 sep 2009 12:30:00 EDT	</pubDate>	<guid>http://www.theheart.org/article/1004981.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1004665.do</link>	<title>Teachable software may help diagnose endocarditis, study shows</title>	<description>		   <![CDATA[ In a proof-of-concept study, researchers developed an artificial neural network with high sensitivity in diagnosing endocarditis related to implanted cardiac rhythm devices. ]]>		</description>	<pubDate>	vie, 18 sep 2009 16:30:57 EDT	</pubDate>	<guid>http://www.theheart.org/article/1004665.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1004611.do</link>	<title>How to shave 10 years off your life: Have high cholesterol, be hypertensive, and smoke</title>	<description>		   <![CDATA[ Smoking, together with high cholesterol and blood pressure, can knock 10 years off life expectancy in middle-aged men, new UK research shows. If excessive weight and glucose intolerance are added in, the difference can be as much as 15 years, they add.  ]]>		</description>	<pubDate>	vie, 18 sep 2009 15:30:13 EDT	</pubDate>	<guid>http://www.theheart.org/article/1004611.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1004483.do</link>	<title>Jonathan Stamler to move to Case Western </title>	<description>		   <![CDATA[ In October, Dr Jonathan S Stamler will become<b> </b>the inaugural director of the Institute for Transformative Molecular Medicine at Case Western, trading Durham, NC for Cleveland, OH.  ]]>		</description>	<pubDate>	vie, 18 sep 2009 13:30:33 EDT	</pubDate>	<guid>http://www.theheart.org/article/1004483.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1004449.do</link>	<title>Pediatric stroke rates may be double previous US estimates </title>	<description>		   <![CDATA[ A new analysis searching both ICD-9 codes and imaging data finds a stroke incidence among children roughly double that previously reported. ]]>		</description>	<pubDate>	vie, 18 sep 2009 12:15:05 EDT	</pubDate>	<guid>http://www.theheart.org/article/1004449.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1004241.do</link>	<title>Merck, Schering-Plough spent $60 million on CME, reports Dow Jones</title>	<description>		   <![CDATA[ The payments were disclosed as part of the investigation by the Senate Special Committee on Aging into CME and include payments to the American Heart Association and the American College of Cardiology, as well as grants to academic institutions for continuing education. ]]>		</description>	<pubDate>	jue, 17 sep 2009 13:45:14 EDT	</pubDate>	<guid>http://www.theheart.org/article/1004241.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1004117.do</link>	<title>Coumarin derivatives affect clopidogrel action</title>	<description>		   <![CDATA[ Another interaction that may affect the response to clopidogrel has been reported, this time with the coumarin derivative phenprocoumon, an anticoagulant commonly used in Europe.  ]]>		</description>	<pubDate>	jue, 17 sep 2009 12:00:47 EDT	</pubDate>	<guid>http://www.theheart.org/article/1004117.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1004085.do</link>	<title>Cutting salt intake in US could save $50 billion a year </title>	<description>		   <![CDATA[ A new economic analysis concludes that regulations to reduce sodium content in processed foods and/or voluntary reductions in salt by companies could save up to $50 billion a year in healthcare costs in the US.  ]]>		</description>	<pubDate>	jue, 17 sep 2009 11:00:49 EDT	</pubDate>	<guid>http://www.theheart.org/article/1004085.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1004041.do</link>	<title>Yet again, CMS declines to expand carotid-stenting coverage </title>	<description>		   <![CDATA[ Hopes for expanded Medicare coverage of carotid-stenting procedures beyond patients at high risk for carotid endarterectomy who have symptomatic carotid artery stenosis <u>&gt;</u>70% have been swatted down by the CMS. ]]>		</description>	<pubDate>	jue, 17 sep 2009 10:00:52 EDT	</pubDate>	<guid>http://www.theheart.org/article/1004041.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1003939.do</link>	<title>Physician, teach thyself: IMPROVE-HF initiative boosts use of evidence-based outpatient care</title>	<description>		   <![CDATA[ The two-year prospective registry-based study of a performance-improvement initiative's effectiveness saw significant jumps, &gt;70% in some cases, in the appropriate use of six out of seven measured evidence-based treatments for patients with chronic heart failure. ]]>		</description>	<pubDate>	mié, 16 sep 2009 17:45:55 EDT	</pubDate>	<guid>http://www.theheart.org/article/1003939.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1003805.do</link>	<title>CAD hospitalizations decline, but HF admissions increase</title>	<description>		   <![CDATA[  ]]>		</description>	<pubDate>	mié, 16 sep 2009 15:15:04 EDT	</pubDate>	<guid>http://www.theheart.org/article/1003805.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1003769.do</link>	<title>FDA issues class I recall of LifePak CR Plus defibrillators</title>	<description>		   <![CDATA[  ]]>		</description>	<pubDate>	mié, 16 sep 2009 14:15:29 EDT	</pubDate>	<guid>http://www.theheart.org/article/1003769.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1003463.do</link>	<title>Newly initiated statin therapy after ACS reduces plaque burden within six weeks</title>	<description>		   <![CDATA[ Initiating statin therapy following an acute coronary syndrome resulted in a significant reduction in coronary atheroma volume after just six weeks, showing that the lipid-lowering drugs act quickly on atherosclerotic plaques.  ]]>		</description>	<pubDate>	mar, 15 sep 2009 16:45:07 EDT	</pubDate>	<guid>http://www.theheart.org/article/1003463.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1003203.do</link>	<title>Black patients less likely to survive in-hospital cardiac arrest</title>	<description>		   <![CDATA[ Black patients who have an in-hospital cardiac arrest are 12% less likely than white patients to survive until discharge&#151;largely due to interhospital differences, researchers report. ]]>		</description>	<pubDate>	mar, 15 sep 2009 16:00:00 EDT	</pubDate>	<guid>http://www.theheart.org/article/1003203.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1003313.do</link>	<title>FAST enough? Intrathoracic monitor bests weight gain in predicting worsening heart failure</title>	<description>		   <![CDATA[ Can an intrathoracic fluid-status monitor, added to an already-indicated ICD or CRT-D device in patients with heart failure, serve as the decompensation early-warning system now provided&#151;unreliably but as recommended in the guidelines&#151;by the bathroom scale?   ]]>		</description>	<pubDate>	mar, 15 sep 2009 14:30:51 EDT	</pubDate>	<guid>http://www.theheart.org/article/1003313.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1003231.do</link>	<title>New ASCOT analysis: Beta blockers not beneficial in hypertensives with tachycardia </title>	<description>		   <![CDATA[ Pulse rate should not be the determinant of which drugs are used in hypertension, conclude the authors of a new subgroup analysis of the ASCOT trial.  ]]>		</description>	<pubDate>	mar, 15 sep 2009 14:15:57 EDT	</pubDate>	<guid>http://www.theheart.org/article/1003231.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1003065.do</link>	<title>Conflicts of interest affect best practices in both industry-funded and non-industry-funded trials </title>	<description>		   <![CDATA[ Clinicians and researchers need to be more aware before signing on to studies about what potential conflicts might arise with the sponsor and set the ground rules for such areas as access to data, manuscript preparation, and right to publish.  ]]>		</description>	<pubDate>	mar, 15 sep 2009 12:00:19 EDT	</pubDate>	<guid>http://www.theheart.org/article/1003065.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1003033.do</link>	<title>Omeprazole, but not pantoprazole, inhibits clopidogrel&#39;s platelet response</title>	<description>		   <![CDATA[ The use of omeprazole significantly reduced the antiplatelet activity of clopidogrel, even with a high maintenance dose of the drug, and other PPIs, such as pantoprazole, should be preferred in clopidogrel-treated patients, according to investigators. ]]>		</description>	<pubDate>	mar, 15 sep 2009 11:15:53 EDT	</pubDate>	<guid>http://www.theheart.org/article/1003033.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1002895.do</link>	<title>Who should get CRT? Resynchronization benefits seen in heart failure with LVEF &amp;gt;35%</title>	<description>		   <![CDATA[ Heart-failure patients with ejection fractions &gt;35% aren't necessarily excluded from the clinical and reverse-remodeling benefits of cardiac resynchronization therapy, suggests yet another study questioning the limits of CRT's current eligibility criteria. ]]>		</description>	<pubDate>	lun, 14 sep 2009 17:15:00 EDT	</pubDate>	<guid>http://www.theheart.org/article/1002895.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1002755.do</link>	<title>Cardiovascular health of Americans is &quot;at a crossroad&quot;</title>	<description>		   <![CDATA[ The number of Americans who have a low cardiovascular risk-factor profile is decreasing, indicating that after two decades of improvement, progress appears to be reversing. The overriding driver of this phenomenon is excessive weight, say the researchers, which in turn contributes to hypertension and diabetes, itself a major contributor to heart disease. ]]>		</description>	<pubDate>	lun, 14 sep 2009 16:00:00 EDT	</pubDate>	<guid>http://www.theheart.org/article/1002755.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1002727.do</link>	<title>ICDs in women with heart failure? Won&#39;t work, suggests meta-analysis </title>	<description>		   <![CDATA[ Implantable defibrillators don't cut all-cause mortality in women with systolic heart failure, proclaim five major clinical trials speaking in unison. An editorial writer cries "foul" on the frequent assumption in clinical practice that outcomes data from randomized trials conducted primarily in men should also apply to women. ]]>		</description>	<pubDate>	lun, 14 sep 2009 16:00:00 EDT	</pubDate>	<guid>http://www.theheart.org/article/1002727.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1002875.do</link>	<title>Medtronic issues advisory over device battery life</title>	<description>		   <![CDATA[  ]]>		</description>	<pubDate>	lun, 14 sep 2009 15:00:00 EDT	</pubDate>	<guid>http://www.theheart.org/article/1002875.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1002379.do</link>	<title>Sponsorship of med-school textbooks in Denmark exposes vulnerable minds to commercial bias</title>	<description>		   <![CDATA[ Results of a new survey showed that a surprising 15% of textbooks had one or more drug or device sponsors and, in two cases, those sponsors had tried to influence the content of the textbooks. ]]>		</description>	<pubDate>	lun, 14 sep 2009 11:45:00 EDT	</pubDate>	<guid>http://www.theheart.org/article/1002379.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1002389.do</link>	<title>Spin not uncommon in negative RCTs, study shows</title>	<description>		   <![CDATA[ French researchers who systematically quantified the prevalence of spin across 72 negative randomized controlled trials say half of the studies put a positive spin on the negative findings in the conclusion sections of the papers.  ]]>		</description>	<pubDate>	lun, 14 sep 2009 11:30:00 EDT	</pubDate>	<guid>http://www.theheart.org/article/1002389.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1002305.do</link>	<title>B-CONVINCED: Maintain beta blockers during acute heart-failure management </title>	<description>		   <![CDATA[ Short-term outcomes are the same whether beta blockers are continued or withheld at hospitalization for acute decompensated heart failure, and there are good reasons to continue them, according to researchers.  ]]>		</description>	<pubDate>	lun, 14 sep 2009 10:30:00 EDT	</pubDate>	<guid>http://www.theheart.org/article/1002305.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1002261.do</link>	<title>Nationwide smoking ban cuts incidence of acute coronary syndrome in nonsmokers</title>	<description>		   <![CDATA[ A smoking ban in public places throughout Iceland resulted in a 21% reduction in ACS among nonsmoking men. ]]>		</description>	<pubDate>	lun, 14 sep 2009 09:45:00 EDT	</pubDate>	<guid>http://www.theheart.org/article/1002261.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1002045.do</link>	<title>Darusentan in resistant hypertension: Data published </title>	<description>		   <![CDATA[ Further studies will be required to fully determine the role of the investigational agent darusentan in resistant hypertension, say the authors of a phase 3 study with the drug.  ]]>		</description>	<pubDate>	dom, 13 sep 2009 18:30:00 EDT	</pubDate>	<guid>http://www.theheart.org/article/1002045.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1001983.do</link>	<title>US cardiologists in short supply; problem could get worse</title>	<description>		   <![CDATA[ The US is short roughly 1600 general cardiologists and 2000 interventional cardiologists. The problem is expected to get worse unless the shortage is addressed, according to an ACC task force.  ]]>		</description>	<pubDate>	vie, 11 sep 2009 13:15:22 EDT	</pubDate>	<guid>http://www.theheart.org/article/1001983.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1001939.do</link>	<title>Homocysteine lowering cuts mortality in early-onset CAD patients </title>	<description>		   <![CDATA[ A new Israeli study finds that treatment with folic acid/B vitamins long term did significantly reduce mortality, but only in those with elevated homocysteine levels at baseline.  ]]>		</description>	<pubDate>	vie, 11 sep 2009 12:00:04 EDT	</pubDate>	<guid>http://www.theheart.org/article/1001939.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1001867.do</link>	<title>Ghost authorship on the wane, but guest authorship still common </title>	<description>		   <![CDATA[ <b><i>UPDATED</i></b> // Compared with a 1996 survey by <i>JAMA</i> editors, a 2008 survey indicates that the practice of having ghost writers pen papers, then not appear as authors, is down to 8%, from 12% in 1996. The practice of inviting a prominent name to appear in the list of authors, without requiring that person to contribute to the research, has held steady at roughly 20%.  ]]>		</description>	<pubDate>	vie, 11 sep 2009 11:00:38 EDT	</pubDate>	<guid>http://www.theheart.org/article/1001867.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1001821.do</link>	<title>Dronedarone in atrial fib trades efficacy for safety in meta-analysis </title>	<description>		   <![CDATA[ The finding, based on eight randomized trials, supports the view that dronedarone is less effective than amiodarone at preventing the arrhythmia's recurrence but doesn't have the older drug's serious toxicities, as suggested by the DIONYSOS trial. ]]>		</description>	<pubDate>	vie, 11 sep 2009 10:15:53 EDT	</pubDate>	<guid>http://www.theheart.org/article/1001821.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1001517.do</link>	<title>Ivabradine BEAUTIFUL in subset of patients with angina and heart rates &amp;gt;70 bpm</title>	<description>		   <![CDATA[ Ivabradine may reduce major cardiovascular events in patients with stable CAD and LV dysfunction who present with limiting angina, BEAUTIFUL investigators say in a post hoc analysis. ]]>		</description>	<pubDate>	jue, 10 sep 2009 16:00:11 EDT	</pubDate>	<guid>http://www.theheart.org/article/1001517.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1001715.do</link>	<title>Cardiac CT protocol identifies perfusion defects, stenoses</title>	<description>		   <![CDATA[ The combined protocol is still considered investigational but suggests that cardiac CT has a potential role in myocardial perfusion imaging for the detection of myocardial ischemia as well as providing information on coronary stenoses. ]]>		</description>	<pubDate>	jue, 10 sep 2009 15:30:20 EDT	</pubDate>	<guid>http://www.theheart.org/article/1001715.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1001691.do</link>	<title>Unresolved depression doubles risk of mortality in post-MI patients</title>	<description>		   <![CDATA[ The latest findings from the SADHART study show that new-onset depression is just as deadly as recurrent depression in patients who have suffered an MI. ]]>		</description>	<pubDate>	jue, 10 sep 2009 15:00:28 EDT	</pubDate>	<guid>http://www.theheart.org/article/1001691.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1001621.do</link>	<title>Novel insulin-resistance variant identified </title>	<description>		   <![CDATA[ A new genetic variant associated with type 2 diabetes has been identified; crucially, this appears to be implicated in insulin resistance rather than having an effect on beta-cell activity in the pancreas.  ]]>		</description>	<pubDate>	jue, 10 sep 2009 14:00:29 EDT	</pubDate>	<guid>http://www.theheart.org/article/1001621.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1001361.do</link>	<title>Taser shocks said to pose little CV risk </title>	<description>		   <![CDATA[ Their heart rates jumped by about 11 bpm and blood pressures rose, but volunteers who received multiple shocks didn't otherwise show abnormal heart rhythms or changes in QRS or corrected-QT intervals.  ]]>		</description>	<pubDate>	mié, 09 sep 2009 17:30:14 EDT	</pubDate>	<guid>http://www.theheart.org/article/1001361.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1001343.do</link>	<title>Quality and completeness of medical literature questioned in two new studies </title>	<description>		   <![CDATA[ Two new studies cast some negative light on the quality and completeness of medical literature, with one showing that less than half of registered studies are published in medical journals, and the other showing major discrepancies between the registered and reported clinical outcomes. ]]>		</description>	<pubDate>	mié, 09 sep 2009 17:00:23 EDT	</pubDate>	<guid>http://www.theheart.org/article/1001343.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1001273.do</link>	<title>MIST correction published; no new information on disputed echo review for PFO/migraine trial</title>	<description>		   <![CDATA[ <b><i>UPDATED</i></b> // The correction in <i>Circulation</i> runs over 700 words long, with a four-page data supplement, but includes no details on residual-shunt data allegedly obtained with an "off-protocol" review of the echocardiographic results.  ]]>		</description>	<pubDate>	mié, 09 sep 2009 14:30:44 EDT	</pubDate>	<guid>http://www.theheart.org/article/1001273.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1001103.do</link>	<title>Implantable ECG loop recorder differentiates between syncope and epilepsy</title>	<description>		   <![CDATA[ Is it syncope? Or is it epilepsy? When there's doubt, an implantable ECG loop recorder can help make the correct diagnosis. ]]>		</description>	<pubDate>	mié, 09 sep 2009 11:00:16 EDT	</pubDate>	<guid>http://www.theheart.org/article/1001103.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1001063.do</link>	<title>New ESC guidelines on infective endocarditis </title>	<description>		   <![CDATA[ The ESC issues new recommendations on the prevention, diagnosis, and treatment of infective endocarditis&#151;"an old but changing disease." The guidance with respect to antibiotic prophylaxis is similar to US advice, experts say. ]]>		</description>	<pubDate>	mié, 09 sep 2009 09:45:03 EDT	</pubDate>	<guid>http://www.theheart.org/article/1001063.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1000965.do</link>	<title>Elderly patients in JUPITER benefit from statin therapy</title>	<description>		   <![CDATA[ The analysis showed that adults <u>&gt;</u>70 years of age had a smaller reduction in relative risk in cardiovascular events compared with those younger than 70 years old but larger absolute reductions, resulting in a lower number needed to treat, particularly for more serious adverse events, according to investigators. ]]>		</description>	<pubDate>	mar, 08 sep 2009 16:30:54 EDT	</pubDate>	<guid>http://www.theheart.org/article/1000965.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1000869.do</link>	<title>ARB/ACE-inhibitor combo not recommended in CHF </title>	<description>		   <![CDATA[ An individual patient-data meta-analysis of the studies to date of angiotensin-receptor blockers and ACE inhibitors in heart failure might help identify those candidates who could benefit from this drug combo, say Swiss researchers. But in the meantime, it should be avoided. ]]>		</description>	<pubDate>	mar, 08 sep 2009 15:45:55 EDT	</pubDate>	<guid>http://www.theheart.org/article/1000869.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1000677.do</link>	<title>UK NICE recommends limited role for prasugrel</title>	<description>		   <![CDATA[ The UK agency that governs reimbursement advises that prasugrel can be used in those ACS patients undergoing PCI who have STEMI, who are diabetic, or who have had a stent thrombosis on clopidogrel. ]]>		</description>	<pubDate>	mar, 08 sep 2009 14:00:15 EDT	</pubDate>	<guid>http://www.theheart.org/article/1000677.do</guid>	</item>	<item>	<link>http://www.theheart.org/article/1000611.do</link>	<title>Experts question routine aspirin for patients with type 2 diabetes</title>	<description>		   <![CDATA[ Not all patients with type 2 diabetes respond in the same way to aspirin, and its routine use in the primary prevention of cardiovascular events in this population needs careful evaluation in large randomized controlled trials, experts say. ]]>		</description>	<pubDate>	mar, 08 sep 2009 12:30:07 EDT	</pubDate>	<guid>http://www.theheart.org/article/1000611.do</guid>	</item></channel></rss>